Literature DB >> 6742271

Hepatitis B exposure incidents in community hospitals.

S E Dandoy, B L Kirkman-Liff, F M Krakowski.   

Abstract

To determine the frequency and distribution of potential hepatitis B exposure incidents among employees of community hospitals, a two-year retrospective study and a one-year prospective study were undertaken in Arizona hospitals. The annual rate of exposure incidents was, respectively, 7.9 and 7.7 per 100 employees; 78 per cent of the incidents were needle punctures. The rate of incidents increased significantly with the size of the hospital and decreased in older employees. While the highest risks of incidents were in phlebotomists, surgical technicians, and laboratory technicians, 14 per cent of all exposures occurred in housekeepers and central supply workers. Only 45 per cent of incidents were reported from employees who would normally expect to be targeted to receive hepatitis B vaccine. The post-exposure use of immune globulins (IG and HBIG) increased from 9 per cent of exposures in the retrospective study to 16 per cent during the prospective study. Exposure incidents occurred at the same rates and in the same occupational groups in community hospitals as previously reported from teaching hospitals and medical centers.

Entities:  

Mesh:

Year:  1984        PMID: 6742271      PMCID: PMC1651950          DOI: 10.2105/ajph.74.8.804

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  12 in total

1.  Needlestick and puncture wounds: definition of the problem.

Authors:  J S Reed; A C Anderson; G R Hodges
Journal:  Am J Infect Control       Date:  1980-11       Impact factor: 2.918

2.  Epidemiology of needle-stick injuries in hospital personnel.

Authors:  R D McCormick; D G Maki
Journal:  Am J Med       Date:  1981-04       Impact factor: 4.965

3.  Viral hepatitis in hospital personnel in Minnesota. Report of a statewide survey.

Authors:  M Osterholm; J S Andrews
Journal:  Minn Med       Date:  1979-09

4.  Epidemiology of hepatitis B in hospital personnel.

Authors:  C P Pattison; J E Maynard; D R Berquist; H M Webster
Journal:  Am J Epidemiol       Date:  1975-01       Impact factor: 4.897

5.  Hepatitis B in a medical center.

Authors:  J P Hansen; J A Falconer; J D Hamilton; F J Herpok
Journal:  J Occup Med       Date:  1981-05

6.  Cost analysis of a needle stick protocol.

Authors:  J B Reuler; J A Campbell
Journal:  Med Decis Making       Date:  1982       Impact factor: 2.583

7.  Hepatitis B in ward and clinical laboratory employees of a general hospital.

Authors:  B S Levy; J C Harris; J L Smith; J W Washburn; J Mature; A Davis; J T Crosson; H Polesky; M Hanson
Journal:  Am J Epidemiol       Date:  1977-10       Impact factor: 4.897

8.  Hepatitis B infection in hospital personnel during an eight-year period; policies for screening and pregnancy in high risk areas.

Authors:  E L Pantelick; A C Steere; H D Lewis; D J Miller
Journal:  Am J Med       Date:  1981-04       Impact factor: 4.965

9.  The newly licensed hepatitis B vaccine. Characteristics and indications for use.

Authors:  S Krugman
Journal:  JAMA       Date:  1982-04-09       Impact factor: 56.272

10.  A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report.

Authors:  W Szmuness; C E Stevens; E A Zang; E J Harley; A Kellner
Journal:  Hepatology       Date:  1981 Sep-Oct       Impact factor: 17.425

View more
  3 in total

1.  The hepatitis B vaccine: utilization decision process and outcomes in community hospitals.

Authors:  B Kirkman-Liff; S Dandoy; G Kallet
Journal:  Health Serv Res       Date:  1985-06       Impact factor: 3.402

2.  Prevalence of hepatitis B serologic markers in community hospital personnel.

Authors:  A A McLean; G R Monahan; D M Finkelstein
Journal:  Am J Public Health       Date:  1987-08       Impact factor: 9.308

3.  Infectivity of medical staff for hepatitis B.

Authors:  H Hofmann; W Tuma; F X Heinz; W Frisch-Niggemeyer; C Kunz
Journal:  Infection       Date:  1988 May-Jun       Impact factor: 3.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.